BridgeMD
New treatment option for Cardiovascular Diseases
Official title ADAPT Micro-Randomized Trial
ClinicalTrials.gov ID: NCT06915220
What this study is testing
- What it's testing
- The goal of this study is to collect quantitative and qualitative data that can be used to optimize the HeartSteps mHealth intervention for physical activity. The current version of the intervention is intended to help patients with heart disease increase and maintain their physical activity long-term.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Must be a patient within the Michigan Medicine clinical system with data available in the electronic health record after January 1, 2020.
- Age \> 18
- Owns and is a daily user of an Android or iPhone smartphone with study supported operating software.
- Understands English to enable informed consent, completion of study-related surveys, and compliance with study notifications.
- Will be completing within 30 days or have completed in the last 30 days the cardiac rehabilitation program at Michigan Medicine based on one of the...
You likely can't join if
- Orthopedic or neurological condition limiting ability to actively engage in moderate intensity physical activity (e.g., brisk walking)
- Greater than mild cognitive impairment
- Wrist too large to wear an activity tracker comfortably. This will be assessed by asking participants "If they have ever had difficulty wearing a...
- Currently receiving palliative care and/or in hospice care
- Severe valvular stenosis or regurgitation
- Unrevascularized left main coronary artery disease (\> 50% obstruction on angiography) or proximal left anterior descending disease (\>70%...
See the full eligibility criteria
- Must be a patient within the Michigan Medicine clinical system with data available in the electronic health record after January 1, 2020.
- Age \> 18
- Owns and is a daily user of an Android or iPhone smartphone with study supported operating software.
- Understands English to enable informed consent, completion of study-related surveys, and compliance with study notifications.
- Will be completing within 30 days or have completed in the last 30 days the cardiac rehabilitation program at Michigan Medicine based on one of the following indications:
- Coronary artery disease (including acute coronary syndromes and stable angina) following percutaneous coronary intervention (PCI)
- Coronary artery disease following coronary artery bypass surgery (CABG)]
- Valve repair or replacement (either surgical or percutaneous)
- Coronary artery disease or an acute coronary syndrome not requiring revascularization
- Orthopedic or neurological condition limiting ability to actively engage in moderate intensity physical activity (e.g., brisk walking)
- Greater than mild cognitive impairment
- Wrist too large to wear an activity tracker comfortably. This will be assessed by asking participants "If they have ever had difficulty wearing a watch in the past due to the band being too small."
- Currently receiving palliative care and/or in hospice care
- Severe valvular stenosis or regurgitation
- Unrevascularized left main coronary artery disease (\> 50% obstruction on angiography) or proximal left anterior descending disease (\>70% obstruction on angiography).
- Exercise-induced ventricular tachycardia
- Cardiac arrest within the prior 6 months
- New York Heart Association (NYHA) class III or IV heart failure
- Pulmonary arterial hypertension treated with inhaled or intravenous pulmonary hypertension-specific therapy
- Ejection fraction \<40%
- Determined to be unsafe for participation in this program as assessed by a clinical nurse or investigative team.
The study team makes the final eligibility decision.
Where it's taking place
- Ann Arbor, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ann Arbor, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.